2021-10-25

Cares Act 2020 required removing guaifenesin from asthma meds

 21.7.12: web.health/diet/

Cares Act 2020 required removing guaifenesin from asthma meds:

. why was primatene recalled?

a competitor claimed that the Cares Act 2020

required removing guaifenesin;

possibly due to it being known that

guaifenesin may cause birth defects.

but that was known at least as far back as 2003.

[ Am Fam Physician. 2003:

https://pubmed.ncbi.nlm.nih.gov/12825840/

Over-the-counter medications in pregnancy

Ronald A Black, D Ashley Hill.

https://www.aafp.org/afp/2003/0615/p2517.html

]


bronkaid`inactive ingredients:

https://bronkaid.com/

*dibasic calcium phosphate *dihydrate, 

magnesium stearate, microcrystalline cellulose, polyethylene glycol,

*polyvinyl alcohol, silicon dioxide, sodium starch glycolate, 

stearic acid, talc.

With the passage of the Cares Act in 2020

the makers of Bronkaid were required to

reformulate the product to remove guaifenesin. 

The new formulation, called Bronkaid® Max, 

still contains the bronchodilator Ephedrine Sulfate.


. the same thing happened to primatene tablets.


Dr.rajivdesai:

https://drrajivdesaimd.com/2021/03/16/over-the-counter-otc-drugs/

. during pregnancy, Guaifenesin has been associated with

an increased risk of neural tube defects.

Table below summarizes safety of Over-the-Counter

Antihistamines, Decongestants, and Expectorants in Pregnancy:

Guaifenesin

Expectorant

Pregnancy risk category C

Safety not established, should be avoided in first trimester.

. Multiple herbals, such as mugwort, blue cohosh, black cohosh, 

goldenseal, juniper berry, chaste berry, rue, and pennyroyal oil, 

are uterine stimulants or abortifacients 

and should be avoided in pregnancy. 


Although ephedra is commonly used during pregnancy

according to patient report, 

it has a significant association with birth defects. 

According to the NBDPS, 

ephedra is associated with anencephaly (OR = 2.8). 

Other weight loss products, with or without ephedra, 

are associated with dextro-transposition of the great vessels

and aortic stenosis.


No comments: